Forrest County General Hospital
Forrest County General Hospital was paid $3.74M by Medicaid between Jan 2018 and Dec 2024, across 98 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
POPLARVILLE, MS 39470
Next to other Critical Access Hospital providers in Mississippi
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,242 | $562K | |
| 2019 | 16,514 | $578K | |
| 2020 | 8,440 | $291K | |
| 2021 | 8,328 | $421K | |
| 2022 | 14,571 | $581K | |
| 2023 | 16,095 | $736K | |
| 2024incomplete | 12,591 | $570K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 8,659 | 7,012 | $1.16M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 2,901 | 2,346 | $477K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.1% | 3,128 | 2,721 | $265K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.5% | 857 | 653 | $207K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.2% | 1,624 | 1,361 | $159K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.0% | 2,587 | 2,129 | $151K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.0% | 8,642 | 559 | $150K |
| 87634 | 2.9% | 2,562 | 2,110 | $110K | |
| 70450 | Computed tomography, head or brain; without contrast material | 2.6% | 1,130 | 967 | $98K |
| 71046 | Radiologic examination, chest; 2 views | 2.5% | 2,247 | 1,844 | $94K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.2% | 2,604 | 2,135 | $82K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.2% | 932 | 785 | $82K |
86 more codes
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.0% | 5,482 | $75K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 1,788 | $60K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 1,529 | $50K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 1,906 | $45K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 1,987 | $44K |
| 71045 | Radiologic examination, chest; single view | 1.1% | 1,077 | $41K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,399 | $34K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 227 | $33K |
| 80053 | Comprehensive metabolic panel | <1% | 4,259 | $32K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 875 | $25K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 241 | $24K |
| 97116 | <1% | 1,977 | $23K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 809 | $18K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,414 | $17K |
| 87428 | <1% | 306 | $14K | |
| 80305 | <1% | 916 | $12K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 891 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,717 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 390 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,394 | $10K |
| 84484 | <1% | 1,316 | $9K | |
| 83880 | <1% | 492 | $9K | |
| 81001 | <1% | 3,602 | $9K | |
| 80061 | Lipid panel | <1% | 705 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 692 | $5K |
| 81025 | <1% | 701 | $5K | |
| 83690 | <1% | 1,069 | $5K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 403 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 27 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 351 | $4K |
| 87430 | <1% | 322 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 39 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 578 | $4K |
| 73630 | <1% | 66 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 37 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 71 | $3K |
| 97597 | <1% | 37 | $2K | |
| 87807 | <1% | 172 | $2K | |
| 80076 | <1% | 292 | $2K | |
| 82150 | <1% | 413 | $2K | |
| 97161 | <1% | 57 | $2K | |
| 82607 | <1% | 126 | $2K | |
| 36592 | <1% | 1,221 | $2K | |
| 82553 | <1% | 292 | $2K | |
| 87081 | <1% | 303 | $1K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 49 | $1K |
| 93000 | <1% | 35 | $1K | |
| 0012A | <1% | 49 | $1K | |
| 87186 | <1% | 158 | $1K | |
| 82550 | <1% | 327 | $996.14 | |
| G0008 | Administration of influenza virus vaccine | <1% | 19 | $951.90 |
| 0011A | <1% | 71 | $941.21 | |
| 73130 | <1% | 14 | $881.24 | |
| J1741 | Injection, ibuprofen, 100 mg | <1% | 23 | $787.00 |
| 73610 | <1% | 23 | $752.76 | |
| A9150 | Non-prescription drugs | <1% | 14 | $750.00 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 20 | $705.74 |
| 83735 | <1% | 109 | $679.97 | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 19 | $649.25 |
| 97166 | <1% | 12 | $558.84 | |
| 85378 | <1% | 118 | $518.01 | |
| 85610 | <1% | 179 | $470.87 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $393.25 |
| 87420 | <1% | 28 | $310.00 | |
| 80176 | <1% | 17 | $229.04 | |
| 82746 | <1% | 14 | $228.76 | |
| 84439 | <1% | 24 | $169.31 | |
| 85730 | <1% | 75 | $167.82 | |
| 87070 | <1% | 17 | $117.54 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,220 | $111.69 |
| 94664 | <1% | 154 | $94.25 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 602 | $89.28 |
| 83615 | <1% | 13 | $87.23 | |
| 87077 | <1% | 15 | $73.66 | |
| 87040 | <1% | 18 | $65.03 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 14 | $57.80 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 186 | $23.40 |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 373 | $16.78 |
| 85379 | <1% | 24 | $9.16 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 20 | $7.80 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 210 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 116 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 274 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 175 | $0.00 |
| A9270 | Non-covered item or service | 0% | 83 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Forrest County General Hospital | Hattiesburg, MS | $81.63M |
| Forrest County General Hospital | Picayune, MS | $21.66M |
| Forrest County General Hospital | Columbia, MS | $9.51M |
| Walthall General Hospital | Tylertown, MS | $6.16M |
| Forrest County General Hospital | Prentiss, MS | $3.80M |
| Forrest County General Hospital | Poplarville, MS | $2.80M |
| Forrest County General Hospital | Picayune, MS | $2.76M |
| Forrest County General Hospital | Richton, MS | $1.58M |
| Forrest County General Hospital | Richton, MS | $1.36M |
| Forrest County General Hospital | Columbia, MS | $1.03M |
| Walthall General Hospital | Tylertown, MS | $953K |
| Forrest General Hospital | Hattiesburg, MS | $850K |
| Forrest County General Hospital | Poplarville, MS | $253K |
| FGH Physician Billing | Hattiesburg, MS | $224K |
| Forrest County General Hospital | Prentiss, MS | $204K |
| Forrest County General Hospital | Picayune, MS | $65K |
| FGH Trauma Surgery Clinic | Hattiesburg, MS | $47K |
| Forrest County General Hospital | Poplarville, MS | $22K |
| Forrest County General Hospital | Richton, MS | $18K |
| Walthall General Hospital | Tylertown, MS | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.